BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15184603)

  • 1. Influence of the amyloid precursor protein locus on dementia in Down syndrome.
    Margallo-Lana M; Morris CM; Gibson AM; Tan AL; Kay DW; Tyrer SP; Moore BP; Ballard CG
    Neurology; 2004 Jun; 62(11):1996-8. PubMed ID: 15184603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome.
    Farrer MJ; Crayton L; Davies GE; Oliver C; Powell J; Holland AJ; Kessling AM
    Neuroreport; 1997 May; 8(7):1645-9. PubMed ID: 9189907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid precursor protein locus and very-late-onset Alzheimer disease.
    Olson JM; Goddard KA; Dudek DM
    Am J Hum Genet; 2001 Oct; 69(4):895-9. PubMed ID: 11500807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.
    Mok KY; Jones EL; Hanney M; Harold D; Sims R; Williams J; Ballard C; Hardy J
    Neurobiol Aging; 2014 Jun; 35(6):1513.e1-5. PubMed ID: 24462566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic tetranucleotide repeat site within intron 7 of the beta-amyloid precursor protein gene and its lack of association with Alzheimer's disease.
    Li L; Perry R; Wu J; Pham D; Ohman T; Harrell LE; Go RC; Fukuchi K
    Hum Genet; 1998 Jul; 103(1):86-9. PubMed ID: 9737782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
    Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
    Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect.
    Engidawork E; Baiic N; Fountoulakis M; Dierssen M; Greber-Platzer S; Lubec G
    J Neural Transm Suppl; 2001; (61):335-46. PubMed ID: 11771756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models.
    Tosh JL; Rhymes ER; Mumford P; Whittaker HT; Pulford LJ; Noy SJ; Cleverley K; ; Walker MC; Tybulewicz VLJ; Wykes RC; Fisher EMC; Wiseman FK
    Sci Rep; 2021 Mar; 11(1):5736. PubMed ID: 33707583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of amyloid precursor protein gene mutation (APP 717 Val-->Ile) in Swedish families with Alzheimer's disease.
    Almqvist E; Lake S; Axelman K; Johansson K; Winblad B
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):151-6. PubMed ID: 8117412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of Alzheimer disease.
    Steele CD
    Nurs Clin North Am; 2000 Sep; 35(3):687-94. PubMed ID: 10957683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the "amyloid cascade hypothesis".
    Hardy J
    FEBS J; 2017 Apr; 284(7):1040-1044. PubMed ID: 28054745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and host factors for dementia in Down's syndrome.
    Schupf N; Sergievsky GH
    Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: no effect on the presence of dementia.
    Tyrrell J; Cosgrave M; McPherson J; Hawi Z; Trulock V; Calvert J; Lawlor B; Gill M
    Am J Med Genet; 1999 Dec; 88(6):616-20. PubMed ID: 10581479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; amyloid-beta precursor protein gene instrumental in hereditary cerebral amyloid angiopathies].
    Haan J; Bakker E; Bornebroek M; Roos RA
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1639-41. PubMed ID: 11552366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extended tau haplotype and the age of onset of dementia in Down syndrome.
    Jones EL; Margallo-Lana M; Prasher VP; Ballard CG
    Dement Geriatr Cogn Disord; 2008; 26(3):199-202. PubMed ID: 18765933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention.
    Head E; Lott IT; Patterson D; Doran E; Haier RJ
    J Alzheimers Dis; 2007 Mar; 11(1):61-76. PubMed ID: 17361036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and down syndrome: from meiosis to dementia.
    Petronis A
    Exp Neurol; 1999 Aug; 158(2):403-13. PubMed ID: 10415146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.